Sign in Register

Drug class

Agents to Treat Opioid (Opiate) Dependence

Agents to treat opioid dependence represent a functional and formulary drug classification used to manage opioid use disorder and support detoxification or long-term maintenance therapy. Read more about Agents to Treat Opioid (Opiate) Dependence

106 drugs in this class 60 manufacturers

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs Opioid Use DisorderTop indication · 112 prescription drugs

Showing 1–9 of 106 drugs

Sort

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2

VISTAPHARM

VIVITROL (naltrexone microspheres)

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

ALKERMES INC

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2

VISTAPHARM

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2

MALLINCKRODT PH

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2

VISTAPHARM

METHADOSE (methadone HCl)

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2

MALLINCKRODT PH

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2

MALLINCKRODT PH

METHADOSE (methadone HCl)

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2

MALLINCKRODT PH

METHADOSE (methadone HCl)

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2

MALLINCKRODT PH

Filter & compare in the drug finder → Opens the drug finder with Agents to Treat Opioid (Opiate) Dependence preselected. Add indication or manufacturer filters there.

About Agents to Treat Opioid (Opiate) Dependence.

Agents to treat opioid dependence represent a functional and formulary drug classification used to manage opioid use disorder and support detoxification or long-term maintenance therapy.

While the phrase serves as a clinical indication grouping rather than a single pharmacologic mechanism, its primary medications include full opioid receptor agonists, partial mu-opioid receptor agonists, and pure opioid receptor antagonists.

These pharmacotherapies function by stabilizing brain neurochemistry, mitigating debilitating withdrawal symptoms, suppressing drug cravings, or blocking the euphoric effects of exogenous opioids.

The class is predominantly indicated for the comprehensive medical management of moderate to severe opioid dependence and addiction, typically integrated with psychosocial and behavioral counseling.

connectrx.com
Agents to treat opioid dependence represent a functional and formulary drug classification used to manage opioid use disorder and support detoxification or long-term maintenance therapy These pharmacotherapies function by stabilizing brain neurochemistry, mitigating debilitating withdrawal symptoms, suppressing drug cravings, or blocking the euphoric effects of exogenous opioids The class is predominantly indicated for the comprehensive medical management of moderate to severe opioid dependence ...
fda.gov
Agents to treat opioid dependence represent a functional and formulary drug classification used to manage opioid use disorder and support detoxification or long-term maintenance therapy
fda.gov
While the phrase serves as a clinical indication grouping rather than a single pharmacologic mechanism, its primary medications include full opioid receptor agonists, partial mu-opioid receptor agonists, and pure opioid receptor antagonists These pharmacotherapies function by stabilizing brain neurochemistry, mitigating debilitating withdrawal symptoms, suppressing drug cravings, or blocking the euphoric effects of exogenous opioids The class is predominantly indicated for the comprehensive medi...
fda.gov
These pharmacotherapies function by stabilizing brain neurochemistry, mitigating debilitating withdrawal symptoms, suppressing drug cravings, or blocking the euphoric effects of exogenous opioids
fda.gov
The class is predominantly indicated for the comprehensive medical management of moderate to severe opioid dependence and addiction, typically integrated with psychosocial and behavioral counseling